文献速递免疫规划卫生政策与健康促进

日本HPV疫苗问题:从社会医学与行为经济学视角回顾我们推动HPV疫苗接种和有效评估该问题的尝试

HPV Vaccine Issues in Japan: A review of our attempts to promote the HPV vaccine and to provide effective evaluation of the problem through social-medical and behavioral-economic perspectives.
PubMed 文献 · Vaccine · 2024-04-14

日本于2010年开始对13-16岁女孩提供HPV疫苗补贴,2013年6月因可能的不良反应报告,厚生劳动省宣布暂停政府推荐,接种率从70%骤降至几乎为零,2021年暂停才结束。疫苗有效性和安全性已有充分记录,但日本仍未恢复可信的接种水平,WHO警告该事件可能对女孩造成实际伤害。作者认为需从行为经济学角度应对疫苗犹豫,政府应迅速采取更有力的宫颈癌控制措施。

要点

  • 日本2013年暂停HPV疫苗政府推荐后,接种率从70%降至几乎为零,2021年才结束暂停。
  • WHO警告日本HPV疫苗事件可能对未受保护女孩造成实际伤害,作者已用真实世界数据证明。
  • 作者认为需从行为经济学角度应对疫苗犹豫,政府应迅速加强宫颈癌控制。

核心结论

  • 日本HPV疫苗有效性和安全性已有充分记录,但接种率仍未恢复到可信水平,作者认为需从行为经济学角度应对疫苗犹豫,政府应迅速采取更有力的宫颈癌控制措施。

研究设计与样本

  • 本文为综述,回顾日本HPV疫苗推广尝试及社会医学与行为经济学视角下的问题评估。

主要发现

  • 日本2010年开始对13-16岁女孩提供HPV疫苗补贴,2013年已常规纳入国家免疫规划为12-16岁女孩接种。
  • 2013年6月因可能的不良反应报告,厚生劳动省宣布暂停政府推荐,接种率从70%的适龄女孩骤降至几乎为零。
  • 政府推荐暂停直到2021年才结束,但日本仍未恢复任何可信水平的HPV疫苗接种。
  • WHO警告日本HPV疫苗事件可能对缺乏保护的女孩造成实际伤害,作者已用真实世界数据证明。

临床怎么用

  • 作者认为,面对当前高水平HPV疫苗犹豫,需从行为经济学角度应对人类决策的非理性,政府应迅速采取更有力的宫颈癌控制措施。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In Japan, subsidies from local and national government programs for HPV vaccination of girls aged 13-16 began in 2010. By 2013, HPV vaccines were being used routinely for vaccinating girls aged 12-16 as part of its national immunization program. However, in June of 2013, in response to reports of possible adverse reactions to the vaccine, Japan's Ministry of Health, Labor, and Welfare (MHLW) announced a 'temporary suspension' of its governmental recommendation for HPV vaccination. The vaccination rate quickly dropped from 70 % of age-eligible girls to almost zero. It was not until 2021 that the government's recommendation suspension finally ended. The efficacy and safety of the HPV vaccine is now well documented, yet Japan has failed to reestablish any credible level of HPV vaccination. The World Health Organization (WHO) warned that Japan's HPV vaccination debacle was likely to result in real harm to the girls who lacked its protection; something we have already demonstrated with real-world data. To reinvigorate the HPV vaccination program in Japan to its prior levels, in the face of the current high level of HPV vaccine hesitancy, we will have to address the irrationality of human decision-making pointed out by behavioral economics. The Japanese government must act expeditiously to promote stronger cervical cancer control measures.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Yagi A, Ueda Y, Kimura T, et al. HPV Vaccine Issues in Japan: A review of our attempts to promote the HPV vaccine and to provide effective evaluation of the problem through social-medical and behavioral-economic perspectives. Vaccine. 2024. PMID: 38616440. doi:10.1016/j.vaccine.2024.03.080

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。